Floatz logo

Therapeutic Asset Ratings

435 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Eloxatin
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2/3BBB (78)
Irinotecan
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2/3BBB (78)
Inno-206
Hematopoietic And Lymphoid System Neoplasm
OHSU Knight Cancer InstituteP4BBB (76)
Cyclophosphamide
Anemia
OHSU Knight Cancer InstituteP4BBB (73)
Letrozole
Breast Carcinoma
OHSU Knight Cancer InstituteP4BBB (73)
Letrozole
Breast Carcinoma
OHSU Knight Cancer InstituteP4BBB (73)
Ruxolitinib
Primary Myelofibrosis
OHSU Knight Cancer InstituteP4BBB (73)
Irinotecan
Ovarian Carcinoma
OHSU Knight Cancer InstituteP2BB (71)
Letrozole
Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer InstituteP2BB (71)
Daunorubicin
Myelodysplastic Syndrome
OHSU Knight Cancer InstituteP3BB (70)
Irinotecan
Breast Carcinoma
OHSU Knight Cancer InstituteP3BB (70)
Vinorelbine
Recurrent Ovarian Carcinoma
OHSU Knight Cancer InstituteP2BB (70)
Carboplatin
Myelodysplastic/Myeloproliferative Neoplasm
OHSU Knight Cancer InstituteP2/3BB (70)
Bortezomib
Hematopoietic And Lymphoid System Neoplasm
OHSU Knight Cancer InstituteP4BB (69)
Idarubicine
Myelodysplastic Syndrome
OHSU Knight Cancer InstituteP4BB (69)
Casodex
Prostate Adenocarcinoma
OHSU Knight Cancer InstituteP3BB (69)
(+)-VINCRISTINE
Stage IV Breast Cancer
OHSU Knight Cancer InstituteP3BB (69)
Azacitidine
Acute Monocytic Leukemia
OHSU Knight Cancer InstituteP2BB (69)
Rapamycin
Myelodysplastic/Myeloproliferative Neoplasm
OHSU Knight Cancer InstituteP2BB (69)
Atezolizumab
Ovarian Carcinoma
OHSU Knight Cancer InstituteP3BB (68)
DEXAMETHASONE
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
OHSU Knight Cancer InstituteP2BB (68)
Eloxatin
Soft Tissue Sarcoma
OHSU Knight Cancer InstituteP2BB (68)
Gdc-0449
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2BB (68)
Ipilimumab
Recurrent Non-Hodgkin Lymphoma
OHSU Knight Cancer InstituteP2BB (68)
(+)-VINCRISTINE
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
OHSU Knight Cancer InstituteP2BB (68)
Showing 1 to 25 of 435 assets
PreviousPage 1 of 18Next